Relevant experiments showed that FTO regulated GPX4 in an m6A-YTHDF2 dependent manner to suppress colon cancer progression (Zhang et al. 2023, Qiao et al. 2024). The gene discussed is GPX4; the disease is malignant colon neoplasm.